# Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy

> **NCT06568445** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 90 (estimated)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** Maintenance at initial treatment sequential as-needed therapy with inhaled budesonide-formoterol(Symbicort 160/4.5) ®）
- **DRUG:** as-needed therapy with inhaled budesonide-formoterol (Symbicort 160/4.5) ®）

## Key facts

- **NCT ID:** NCT06568445
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-12
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-09-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06568445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06568445, "Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06568445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*